Skip to main content
PMC home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1996 Feb;116(1):71–89. doi: 10.1017/s0950268800058970

The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes.

J R Williams 1, D J Nokes 1, G F Medley 1, R M Anderson 1
PMCID: PMC2271247  PMID: 8626006

Abstract

Complex hepatitis B (HBV) epidemiology makes it difficult to evaluate and compare effectiveness of different immunization policies. A method for doing so is presented using a mathematical model of HBV transmission dynamics which can represent universal infant and adolescent vaccination strategies and those targeted at genito-urinary (GU) clinic attenders and infants born to infectious mothers. Model structure, epidemiological underpinning, and parameterization, are described. Data from the UK National Survey of Sexual Attitudes and Lifestyles is used to define patterns of sexual activity and GU clinic attendance; data deficiencies are discussed, in particular that of UK seroprevalence of HBV markers stratified by age, sex, and risk factors. General model predictions of endemic HBV marker prevalence in homosexual and heterosexual populations seem consistent with published UK data. The simulations exhibit non-linearities in the impact of different vaccination strategies. Estimated number of carriers prevented per vaccine dose for each strategy provides a measure of costs and benefits, varying temporally over the course of a programme, and with level of vaccine coverage. Screening before vaccination markedly increases payback per dose in homosexuals but not in heterosexuals; mass infant vaccination gives the poorest effectiveness ratio and vaccination of infants after antenatal screening the best; in general, increasing vaccine coverage yields lower pay-back per dose. The model provides a useful framework for evaluating costs and benefits of immunization programmes, but for precise quantitative comparison more UK epidemiological data is urgently needed.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alward W. L., McMahon B. J., Hall D. B., Heyward W. L., Francis D. P., Bender T. R. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis. 1985 Apr;151(4):604–609. doi: 10.1093/infdis/151.4.604. [DOI] [PubMed] [Google Scholar]
  2. Asch D. A. Cost and effectiveness of hepatitis B immunization. Ann Intern Med. 1993 Sep 15;119(6):536–537. doi: 10.7326/0003-4819-119-6-199309150-00026. [DOI] [PubMed] [Google Scholar]
  3. Banatvala J. E., Chrystie I. L., Palmer S. J., Kenney A. Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic. Lancet. 1990 Apr 7;335(8693):859–860. doi: 10.1016/0140-6736(90)90977-d. [DOI] [PubMed] [Google Scholar]
  4. Barbara J. A., Howell D. R., Cleghorn T. E., Cameron C. H., Briggs M., Dane D. S. A comparison of different methods of screening blood donations for HBsAg. Vox Sang. 1977;32(1):4–9. doi: 10.1111/j.1423-0410.1977.tb00597.x. [DOI] [PubMed] [Google Scholar]
  5. Bhatti N., Gilson R. J., Beecham M., Williams P., Matthews M. P., Tedder R. S., Weller I. V. Failure to deliver hepatitis B vaccine: confessions from a genitourinary medicine clinic. BMJ. 1991 Jul 13;303(6794):97–101. doi: 10.1136/bmj.303.6794.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bloom B. S., Hillman A. L., Fendrick A. M., Schwartz J. S. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Ann Intern Med. 1993 Feb 15;118(4):298–306. doi: 10.7326/0003-4819-118-4-199302150-00009. [DOI] [PubMed] [Google Scholar]
  7. Brook M. G., Lever A. M., Kelly D., Rutter D., Trompeter R. S., Griffiths P., Thomas H. C. Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: three years experience in a London hospital. Q J Med. 1989 Apr;71(264):313–317. [PubMed] [Google Scholar]
  8. Collins M., Heptonstall J. Occupational acquisition of acute hepatitis B infection by health care workers: England and Wales, 1985-93. Commun Dis Rep CDR Rev. 1994 Nov 11;4(12):R153–R155. [PubMed] [Google Scholar]
  9. Derso A., Boxall E. H., Tarlow M. J., Flewett T. H. Transmission of HBsAg from mother to infant in four ethnic groups. Br Med J. 1978 Apr 15;1(6118):949–952. doi: 10.1136/bmj.1.6118.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Edmunds W. J., Medley G. F., Nokes D. J., Hall A. J., Whittle H. C. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci. 1993 Aug 23;253(1337):197–201. doi: 10.1098/rspb.1993.0102. [DOI] [PubMed] [Google Scholar]
  11. Evans B. A., McCormack S. M., Bond R. A., MacRae K. D., Thorp R. W. Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic. Br Med J (Clin Res Ed) 1988 Feb 13;296(6620):473–475. doi: 10.1136/bmj.296.6620.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fine P. E. Herd immunity: history, theory, practice. Epidemiol Rev. 1993;15(2):265–302. doi: 10.1093/oxfordjournals.epirev.a036121. [DOI] [PubMed] [Google Scholar]
  13. Hart G. J., Dawson J., Fitzpatrick R. M., Boulton M., McLean J., Brookes M., Parry J. V. Risk behaviour, anti-HIV and anti-hepatitis B core prevalence in clinic and non-clinic samples of gay men in England, 1991-1992. AIDS. 1993 Jun;7(6):863–869. doi: 10.1097/00002030-199306000-00016. [DOI] [PubMed] [Google Scholar]
  14. King R., Johnson P. J., White Y. S., Smith H. M., Williams R. Frequency of asymptomatic hepatitis types B and C in an inner city community and relation to possible risk factors. Q J Med. 1991 Aug;80(292):641–649. [PubMed] [Google Scholar]
  15. Kitchen A. D., Harrison T. J., Meacock T. J., Zuckerman A. J., Harrison J. F. Incidence and significance of hepatitis B core antibody in a healthy blood donor population. J Med Virol. 1988 May;25(1):69–75. doi: 10.1002/jmv.1890250110. [DOI] [PubMed] [Google Scholar]
  16. Loveday C., Mercey D. The prevalence of human retroviral infections in female patients attending a central London sexually transmitted disease clinic: 1985-1990. Genitourin Med. 1993 Feb;69(1):31–34. doi: 10.1136/sti.69.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Redeker A. G., Mosley J. W., Gocke D. J., McKee A. P., Pollack W. Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med. 1975 Nov 20;293(21):1055–1059. doi: 10.1056/NEJM197511202932101. [DOI] [PubMed] [Google Scholar]
  18. Smith H. M., Alexander G. J., Webb G., McManus T., McFarlane I. G., Williams R. Hepatitis B and delta virus infection among "at risk" populations in south east London. J Epidemiol Community Health. 1992 Apr;46(2):144–147. doi: 10.1136/jech.46.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES